A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation

Nature Immunology

Volumn 2, Issue 4, 2001, Pages 353-360

  Hogan, Simon P ^a   Mishra, Anil ^a   Brandt, Eric B ^a   Royalty, Michael P ^a   Pope, Samuel M ^a   Zimmermann, Nives ^a   Foster, Paul S ^b   Rothenberg, Marc E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA CHEMOKINE; CYTOKINE; EOSINOPHIL CHEMOTACTIC FACTOR; EOTAXIN;

ANIMAL; ARTICLE; ELECTRON MICROSCOPY; EOSINOPHIL; EOSINOPHILIA; GASTROINTESTINAL DISEASE; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; MOUSE; MOUSE MUTANT; ORAL DRUG ADMINISTRATION; PATHOLOGY; TH2 CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CYTOKINES; EOSINOPHILIA; EOSINOPHILS; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMATION; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; TH2 CELLS;

EID: 0035318284     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/86365     Document Type: Article

References (47)

1. Sampson, H. A. Food allergy. Part I: immunopathogenesis and clinical disorders. J. Allergy Clin. Immunol. 103, 717-728 (1999).
2. Furuta, G. T., Ackerman, S. J. & Wershil, B. K. The role of the eosinophil in gastrointestinal diseases. Curr. Opin. Gastroenterol. 11, 541-547 (1995).
3. Sampson, H. A. Food allergy. J. Am. Med. Assoc. 278, 1883-1894 (1997).
4. Kelly, K. J. Eosinophilic gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 30 Suppl 28-35 (2000).
5. Gleich, G. J., Frigas, E., Loegering, D. A., Wassom, D. L. & Steinmuller, D. Cytoxic properties of the eosinophil major basic protein. J. Immunol. 123, 2925-2927 (1979).
6. Klein, N. C., Hargrove, R. L., Sleisenger, M. H. & Jeffries, G. H. Eosinophilic gastroenteritis. Medicine (Baltimore) 49, 299-319 (1970).
7. Cello, J. P. Eosinophilic gastroenteritis: a complex disease entity. Am. J. Med. 67, 1097-1114 (1979).
8. Torpier, G. et al. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin. Exp. Immunol. 74, 404-408 (1988).
9. Vandezande, L. M. et al. Interleukin-5 immunoreactivity and mRNA expression in gut mucosa from patients with food allergy. Clin. Exp. Allergy 29, 695-702 (1999).
10. Keshavarzian, A. et al. Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology 88, 1041-1049 (1985).
11. Talley, N. J., Shorter, R. G., Phillips, S. F. & Zinsmeister, A. R. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 31, 54-58 (1990).
12. Desreumaux, P. et al. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology 110, 768-774 (1996).
13. Lowichik, A. & Weinberg, A. G. A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Mod. Pathol. 9, 110-114 (1996).
14. Weller, P. F. et al. Role of the eosinophil in allergic reactions. Eur. Respir. J. 22, 109s-115s (1996).
15. Gleich, G. J. & Kita, H. Bronchial asthma: lessons from murine models. Proc. Natl Acad. Sci. USA 94, 2101-2102 (1997).
16. Schleimer, R. P. & Bochner, B. S. The role of adhesion molecules in allergic inflammation and their suitability as targets of antiallergic therapy. Clin. Exp. Allergy 28 Suppl 3, 15-23 (1998).
17. Cieslewicz, G. et al. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J. Clin. Invest. 104, 301-303 (1999).
18. Rothenberg, M. E. Eosinophilia. N. Engl. J. Med. 338, 1592-1600 (1998).
19. Gutierrez-Ramos, J. C., Lloyd, C. & Gonzalo, J. A. Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. Immunol. Today 20, 500-504 (1999).
20. Garcia-Zepeda, E. A. et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med. 2, 449-456 (1996).
21. Hogan, S. P., Mishra, A., Brandt, E. B., Foster, P. S. & Rothenberg, M. E. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc. Natl Acad. Sci. USA 97, 6681-6686 (2000).
22. Rothenberg, M. E. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Am. J. Respir. Cell Mol. Biol. 21, 291-295 (1999).
23. Mishra, A., Hogan, S. P., Brandt, E. B. & Rothenberg, M. E. Peyer's patch eosinophils: identification, characterization, and regulation by mucosal allergen exposure, interleukin-5, and eotaxin. Blood 96, 1538-1544 (2000).
24. Mishra, A., Hogan, S. P., Lee, J. J., Foster, P. S. & Rothenberg, M. E. Fundamental signals regulate eosinophil homing to the gastrointestinal tract. J. Clin. Invest 103, 1719-1727 (1999).
25. Lirwin, A., Flanagan, M. & Michael, J. G. Microencapsulation. The future of oral immunotherapy? Biodrugs 9, 261-270 (1998).
26. Dvorak, A. M. et al. Ultrastructural identification of exocytosis of granules from human gut eosinophils in vivo. Int. Arch. Allergy Immunol. 102, 33-45 (1993).
27. Lloyd, C. M. et al. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J. Exp. Med. 191, 265-274 (2000).
28. Grimaldi, J. C. et al. Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3). J. Leukoc. Biol. 65, 846-853 (1999).
29. Collins, P. D., Marleau, S., Griffiths-Johnson, D. A. Jose, P. J. & Williams, T. J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182, 1169-1174 (1995).
30. Mestecky, J. et al. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J. Clin. Invest. 61, 731-737 (1978).
31. Michael, J. G. The role of digestive enzymes in orally induced immune tolerance. Immunol. Invest. 18, 1049-1054 (1989).
32. Jaffe, J. S. et al. Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J. Clin. Immunol. 14, 299-309 (1994).
33. Gleich, G. J., Adolphson, C. R. & Leiferman, K. M. The biology of the eosinophilic leukocyte. Annu. Rev. Med. 44, 85-101 (1993).
34. Abu-Ghazaleh, R. I., Fujisawa, T. Mestecky, J., Kyle, R. A. & Gleich, G. J. IgA-induced eosinophil degradation. J. Immunol. 142, 2393-2400 (1989).
35. Evans, C. M., Fryer, A. D., Jacoby, D. B., Gleich, G. J. & Costello, R. W. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J. Clin. Invest. 100, 2254-2262 (1997).
36. Adamko, D. J., Yost, B. L., Gleich, G. J., Fryer, A. D. & Jacoby, D. B. Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects. J. Exp. Med. 190, 1465-1478 (1999).
37. Lin, S. et al. Expression of muscarinic receptor subtypes in rat gastric smooth muscle: effect of M3 selective antagonist on gastric motility and emptying. Dig. Dis. Sci. 42, 907-914 (1997).
38. Talley, N. J., Kephart, G. M., McGovern, T. W. Carpenter, H. A. & Gleich, G. J. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology 103, 137-145 (1992).
39. Stelts, D. et al. Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am. J. Respir. Cell Mol. Biol. 18, 463-470 (1998).
40. Erjefalt, J. S. & Persson, C. G. New aspects of degranulation and fates of airway mucosal eosinophils. Am. J. Respir. Crit. Care Med. 161, 2074-2085 (2000).
41. Mishra, A., Hogan, S. P., Brandt, E. B. & Rothenberg, M. E. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J. Clin. Invest. 107, 83-90 (2001).
42. Lee, R. G. Marked eosinophilia in esophageal mucosal biopsies. Am. J. Surg. Pathol. 9, 475-479 (1985).
43. Dobbins, J. W., Sheahan, D. G. & Behar, J. Eosinophilic gastroenteritis with esophageal involvement. Gastroenterology 72, 1312 (1977).
44. Kelly, K. J. et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 109, 1503-1512 (1995).
45. Woerly, G. et al. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type I cytokines (interleukin 2 and interferon gamma). Inhibition by immunoglobulin A complexes. J. Exp. Med. 190, 487-496 (1999).
46. Shi, H. Z., Humbles, A., Gerard, C. Jin, Z. & Weller, P. F. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J. Clin. Invest 105, 945-953 (2000).
47. Rothenberg, M. E., MacLean, J. A., Pearlman, E., Luster, A. D. & Leder, P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185, 785-790 (1997).